Objective: Since the etiology of pregnancy losses during first trimester has not still been clear, we aim to analyze the relationship between vitamin D deficiency and early pregnancy losses.
Introduction
25(OH) D levels have been found below the effective levels in most of the reproductive age women and newborns worldwide [1] . Based on this information, replacement programs started to be implemented in many countries. Moreover, the need for replacement is due to the multiple functions of this hormone. Vitamin D deficiency is associated with many clinical entities. Increasing evidence suggests that this hormone is linked to many diseases. In this respect, its effects have been continuously emphasized outside the skeletal system including also its critical role in pregnancy loss. Studies indicate that the effects of the vitamin D on the immune system play an important role in the sustainability of the pregnancy [2] . According to these studies, vitamin D acts as an immunomodulator and has been shown to contribute to successful decidualization by exerting significant local anti-inflammatory activity [3] .
Vitamin D effects cellular and humoral immunity in different ways. One of the important factors in keeping the pregnancy health is the T-helper (Th) 2 response. In this context, Vitamin D has been shown to trigger Th2 mediated cytokines (IL-4, IL-5, IL-6, IL-9, IL-10 and IL-13) and inhibit Th1 cells and the production of related cytokines [4] . This is in line with studies showing that Th1 mediated cytokines decrease during the healthy pregnancy and Th2 mediated cytokines increase [5, 6] . Since the pregnancy losses during first-trimester are still not clear, we aimed to evaluate the role of vitamin D deficiency during pregnancy.
Material and Method
The study was conducted on pregnant women who admitted to Medipol University Hospital Department of Gynecology and Obstetrics between January 2014 and December 2016. Before the study was undertaken, permission was obtained from the University's board of ethics along with the consents of all the patients. The study was built on 4 groups. The week of pregnancy was calculated according to the last menstrual period and confirmed by ultrasonography examination. Group 1 (n=50) consisted of patients with 7-10 weeks of pregnancy with vaginal bleeding and diagnosed as early pregnancy loss after ultrasound examination. Group 2 (n=50) consisted of patients with viable pregnancy at 7-10 gestational weeks, no abnormal gynecological history and maintained normal pregnancy with follow-up until the week 12 of pregnancy. Group 3 (n=50) consisted of non-pregnant patients examined for prepregnancy along with a healthy pregnancy history. Group 4 (n=50) consisted of non-gravid women with history 1 or more first trimester pregnancy loss.
Citation
The women between 18-35 years old were involved in the study. The nulliparous pregnant women were included in the study out of the group of pregnancy. The women with a known metabolic disease (thyroid dysfunction, Diabetes etc.), uterine malformation, a severe liver or kidney disease, infection with rubella, toxoplasma, cytomegalovirus and herpes virus, and history of pregnancy loss with chromosomal abnormality excluded. The group 1 and the group 2 were classified as the groups of early pregnancy while the group 3 and the group 4 were considered to be the group of non-gravid.
The clinical parameters comprised of age, body mass index (BMI), socio-economic status and gestational age. Blood samples were obtained in an effort to measure 25 (OH) D and calcium (ca) levels of all the women. The demographic and laboratory data of all the patients were compared to one another. The range between 30 and 80 ng/ml was considered optimal, 20 to 29 ng/ml as insufficiency and 20 ng/ml and less as deficiency.
Statistical analysis:
The data were analyzed using Statistical Package Social Sciences (SPSS) Version 15.0 (Inc., Chicago, IL, USA). The descriptive statistics were expressed as standard deviations and mean, categorical data (%) for numerical variables. The Kolmogorov-Smirnov test was performed to analyze the normal distribution of the variables, and the MannWhitney U test was performed for subgroup comparisons. P value <0.05 was considered statistically significant. The abnormal distribution was analyzed through nonparametric tests. For multiple group comparisons, One-Way ANOVA (Robust Test: Brown-Forsythe) and Kruskal-Wallis H test post hoc analyzes [Nonparametric post-hoc test (Miller, 1966) ] were put to use.
Results
Comparisons of sociodemographic and clinical data of the groups are presented in (Table 1 ). There was no statistically significant difference among the four groups in terms of age, BMI and socio-economic status (p>0.05). There was no significant difference in gestational ages between the groups of early pregnancy.
( Table 2 ) offers a comparison of laboratory data for the groups. The serum 25(OH)D levels for the groups turned out to be 47.64 ± 3.2 (95% CI: 44.4-50.8 ng/ml) for the normal group of pregnancy, 27.3 ± 1.2 (95% CI: 26.1 -28.5 ng/ml) for the group of early pregnancy loss, group 1, 38.5 ± 5.1 (95%CI: 33.4 -43.6 ng/ml) for the group 3 and 11.6 ± 4.2 (95% CI: 7.9 -15.6 ng/ml) for the group 4 respectively. The ANOVA test associated with 25(OH) D revealed significant differences among the 4 groups. 25(OH) D concentrations were highest in the group of normal pregnancy (group 2), and the lowest in group 4. The low serum 25(OH) D levels amounted to 42% (n=21) for the group 1 and 98% (n=49) for the group 4. However, this ratio accounted for 2% (n=1) in the non-gravid group (group 2) and 4% (n=2) in the group 3.
There was a statistically significant difference between serum 25(OH) D levels in the group 1 and the group 2, and between the group 3 and the group 4 (p = 0.000). There was a strong correlation between low 25(OH) D levels and the pregnancy loss (odds ratio (OR): 1.70, 95% CI: 1.2-2.3, p <0.001). When the calcium levels were compared (table 2), serum ca levels were found significantly different (p = 0.021, p = 0.000, respectively). The calcium levels were significantly lower for the group 1 of pregnancy loss group than for the group of normal pregnancy (group 2) and non-gravid (group 3-4) (p=0.005, p=0.033 respectively). 
Discussion
The effects of vitamin D on bone and calcium metabolism are well understood, while the roles on the cardiovascular system, central nervous system, immune system and reproductive system are still subject to researches. Vitamin D is considered to be a systemic steroid hormone [7] and basically strengthens innate immunity and regulates adaptive immunity [8] .
Immune system cells; macrophages, dendritic cells, T cells and B cells has vitamin D receptor (VDR) and can produce 1,25-dihydroxyvitamin D; the active form of vitamin D [9] .
The effects on the immune system are mainly through the balance between Th1 / Th2 cells. 1, 25-dihydroxyvitamin D is an inhibitor of Th1 cell proliferation and cytokines; it activates and upregulates Th2 cells and its functions [10] . Studies have shown that vitamin D deficiency plays a role in natural killer cell (NK) cytotoxicity, and it has been shown that the peripheral effects and cytotoxicity of CD19 + B, CD 56 + NK cells in women with vitamin D deficiency are higher [3] . With these immune modulatory effects of vitamin D, it has been speculated that vitamin D could act as an immune regulator during implantation and play an important role in regulation of reproductive function [3] .
Pregnancy is basically a process that's carried out on an immunological basis where the host-antigen relationship between mother and fetus is regulated [11] . Maternal immunosuppression is essential for a healthy pregnancy and humoral immunity will dominate during pregnancy. Maternal immunosuppression is provided by suppression of Th1 and NK cells and altering the balance of Th1/Th2 cells; thus rejection of the pregnancy is prevented3. While overexpression of Th1 cytokines may induce abortion, excessive Th2 activity is also one of the causes [12] . Lee et al. showed dominant Th1 immune response and increased NK cell levels and cytotoxicity in women with idiopathic recurrent pregnancy loss and multiple implantation failures (MIF) after in vitro fertilization POJ Gyn Obst Res. 1(1): 1-5 (2017) and embryo transfer cycles [13] .
In early pregnancy, trophoblasts produce and respond to vitamin D, and some investigators have demonstrated that vitamin D triggers local anti inflammatory responses and induces decasualization for healthy pregnancy [14] .
A. Halhali et al. injected 1, 25-dihydroxyvitamin D3 into uterine cavity of female rats at Day 5 of pseudopregnancy, at the time when endometrial sensitivity is maximal for the decidual reaction [15] , and showed that it significantly increased uterine weight and induced decidual reaction [16] Yayla et al. evaluated placental volume and placental volumetric mean gray values in patients with vitamin D deficiency in first trimester of pregnancy. Vitamin D concentration was significantly associated with the placental volume. They recommend vitamin D screening and supplementation in first trimester of pregnancy [17] .
Studies showed that maternal vitamin D deficiency is also associated with poor obstetric outcomes and pregnancy complications like preeclampsia, gestational diabetes (GDM), abortus, preterm birth, small for gestational age (SGA) [18] .
Our study showed that low vitamin D and calcium levels are associated with early pregnancy loss. Women with history of abortion had lower vitamin D levels than healthy pregnants and non-pregnant controls. This can be due to immunomodulator and anti inflammatory effects of vitamin D [19] . Hou et al. found low maternal serum vitamin D and 1 alpha hydroxylase (CYP27B1) levels in early pregnancy losses [20] . This can be due to low vitamin D and CYP27B1 levels in chorionic villi and decidua [21] .
Anti-phospholipid syndrome is one of the well established cause of recurrent miscarriage. Several studies showed that low vitamin D levels are related with positive APA, anti-nuclear antigen antibody, anti-ss DNA and TPO antibody in women with recurrent pregnancy loss [22] [23] .
As a steroid hormone vitamin D has a significant role during pregnancy from implantation and decidualization phases of pregnancy. Although the current literature relates vitamin D deficiency to poor obstetric outcomes, conflicting results have been reported that vitamin D supplementation improves outcomes. There is insufficient data to recommend screening all pregnant women for vitamin D deficiency [24] .
It is not possible to recommend routine screening and supplementation of vitamin D in early pregnancy, as prognosis of pregnancies receiving supplementation and the incidence of pregnancy related complications in follow-up are not known and well designed studies with long term follow up results needed. However it is advisable to consider prepregnacy vitamin D screening in women having first trimester pregnancy loss history.
